GlobalData forecasts ADC NSCLC market to reach $3.9 bn in 2032
Express Pharma
MAY 27, 2025
The ADC late development pipeline in NSCLC is active, with 29 Phase III ongoing global clinical trials sponsored by big pharmaceutical companies, including Merck & Co., AbbVie, AstraZeneca, and Daiichi Sankyo. 7MM: The US, France, Germany, Italy, Spain, the UK, and Japan.
Let's personalize your content